Insider Transactions in Q1 2022 at Jazz Pharmaceuticals PLC (JAZZ)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2022
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,288
+0.37%
|
$75,992
$59.13 P/Share
|
|
Mar 05
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,929
-5.96%
|
$3,355,137
$153.96 P/Share
|
|
Mar 05
2022
|
Renee D Gala President & COO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
720
-1.93%
|
$110,160
$153.96 P/Share
|
|
Mar 05
2022
|
Robert Iannone EVP, Global Head of R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
1,327
-3.27%
|
$203,031
$153.96 P/Share
|
|
Mar 05
2022
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,228
-3.59%
|
$187,884
$153.96 P/Share
|
|
Mar 05
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,836
-11.62%
|
$280,908
$153.96 P/Share
|
|
Mar 05
2022
|
Kim Sablich EVP, GM of U.S. |
SELL
Payment of exercise price or tax liability
|
Direct |
746
-2.4%
|
$114,138
$153.96 P/Share
|
|
Mar 05
2022
|
Daniel N Swisher Jr President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,802
-7.74%
|
$734,706
$153.96 P/Share
|
|
Mar 03
2022
|
Patricia Carr SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,488
+23.07%
|
-
|
|
Mar 03
2022
|
Bruce C Cozadd Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
44,788
+10.86%
|
-
|
|
Mar 03
2022
|
Renee D Gala President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
11,730
+23.9%
|
-
|
|
Mar 03
2022
|
Robert Iannone EVP, Global Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
11,374
+21.89%
|
-
|
|
Mar 03
2022
|
Finbar Larkin SVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
4,621
+17.89%
|
-
|
|
Mar 03
2022
|
Neena M Patil EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,886
+20.62%
|
-
|
|
Mar 03
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,839
+19.55%
|
-
|
|
Mar 03
2022
|
Kim Sablich EVP, GM of U.S. |
BUY
Grant, award, or other acquisition
|
Direct |
9,953
+24.25%
|
-
|
|
Mar 03
2022
|
Daniel N Swisher Jr President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
13,507
+17.88%
|
-
|
|
Mar 03
2022
|
Christopher J. Tovey EVP, COO & Managing Director E |
BUY
Grant, award, or other acquisition
|
Direct |
7,820
+31.59%
|
-
|
|
Mar 02
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
6,000
-1.82%
|
$900,000
$150.0 P/Share
|
|
Mar 01
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
6,501
-0.65%
|
$884,136
$136.62 P/Share
|
|
Mar 01
2022
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,700
+2.81%
|
$446,200
$46.83 P/Share
|
|
Feb 01
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
6,372
-0.64%
|
$885,708
$139.2 P/Share
|
|
Feb 01
2022
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,700
+2.84%
|
$446,200
$46.83 P/Share
|
|
Jan 03
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
5,791
-0.44%
|
$741,248
$128.08 P/Share
|
|
Jan 03
2022
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,700
+2.87%
|
$446,200
$46.83 P/Share
|
|
Jan 03
2022
|
Daniel N Swisher Jr President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,624
-3.24%
|
$212,744
$131.01 P/Share
|